10.1056/NEJM199312303292706 68 MorrisonR
From physiology to pharmacology Our discovery of GLP-1 as a satiety hormone was patented in collaboration with the pharmaceutical company Novo Nordisk A/S in November 1996 [7] (I receive no royalty or other payments)
and Mounjaro (15mg dose, 4 pens) in the U.S., Japan, and the Netherlands
Its also important to note that there havent been any studies investigating the long-term use of GHK-Cu in humans, so we currently cant speak to the effects of extended treatment
Doctors also prescribe them for people with obesity or overweight with related health conditions, to help them lose weight
Semaglutide works by interacting with the brains appetite control centre, the hypothalamus, to lower hunger and food-seeking behaviours